LeMaitre Vascular

Timeline

1. Jun 9, 2023 Trial start —: Post-Market Registry in Europe and US for the Use of VascuCelTM source ↗
2. Jan 11, 2023 Trial start Not phased (device or behavioral study): A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters source ↗
3. Jan 11, 2022 Trial start Not phased (device or behavioral study): A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter source ↗
4. Nov 27, 2020 Trial start —: LeMaitre LifeSpan® ePTFE Vascular Graft Retrospective Registry source ↗
5. Aug 28, 2020 Trial start —: Prospective and Non-randomized Registry of CardioCel 3D source ↗
6. Aug 15, 2017 Trial start Not phased (device or behavioral study): Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair source ↗
7. Jul 13, 2017 Trial start Not phased (device or behavioral study): Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair source ↗
8. 2004-03 Trial start Phase 2: Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts source ↗

Upcoming milestones

• 2027-06 (ESTIMATED) · Not phased · A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter · NCT05386277
• 2027-06 (ESTIMATED) · Not phased · A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters · NCT05386342

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 8

Open jobs 20

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.